Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low‐Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison

BACKGROUND. Daratumumab (a human CD38‐directed monoclonal antibody) and pomalidomide (an immunomodulatory drug) plus dexamethasone are both relatively new treatment options for patients with heavily pretreated multiple myeloma. A matching adjusted indirect comparison (MAIC) was used to compare absol...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Van Sanden, Suzy, Ito, Tetsuro, Diels, Joris, Vogel, Martin, Belch, Andrew, Oriol, Albert
Format: Artigo
Sprog:Inglês
Udgivet: AlphaMed Press 2017
Fag:
Academia‐Pharma Intersect: Hematologic Malignancies
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905688/
https://ncbi.nlm.nih.gov/pubmed/29192016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0103
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker